139 related articles for article (PubMed ID: 21510453)
1. [Antiepileptic drug lacosamide(vimpat)].
Zenkov LR
Zh Nevrol Psikhiatr Im S S Korsakova; 2010; 110(10):72-9. PubMed ID: 21510453
[No Abstract] [Full Text] [Related]
2. [Lacosamide--oral administration (Vimpat) ].
Duh D; Peeters S
J Pharm Belg; 2011 Mar; (1):25-6. PubMed ID: 21473129
[No Abstract] [Full Text] [Related]
3. [Lacosamide in the treatment of epilepsy].
Petrukhin AS; Voronkova KV; Pylaeva OA
Zh Nevrol Psikhiatr Im S S Korsakova; 2012; 112(6 Pt 2):65-71. PubMed ID: 22983249
[TBL] [Abstract][Full Text] [Related]
4. [Lacosamide (vimpat). Prospects for clinical application].
Rudakova IG; Vlasov PN; Lipatova LV; Voronkova KV
Zh Nevrol Psikhiatr Im S S Korsakova; 2017; 117(9):147-152. PubMed ID: 29053136
[TBL] [Abstract][Full Text] [Related]
5. Successful treatment for refractory convulsive status epilepticus by non-parenteral lacosamide.
Tilz C; Resch R; Hofer T; Eggers C
Epilepsia; 2010 Feb; 51(2):316-7. PubMed ID: 19674050
[TBL] [Abstract][Full Text] [Related]
6. Lacosamide-induced rash.
Koubeissi MZ; Vismer M; Ehrlich A
Epileptic Disord; 2014 Sep; 16(3):380-3. PubMed ID: 25035958
[TBL] [Abstract][Full Text] [Related]
7. [Lacosamide. A new antiepileptic drug as adjunctive therapy in patients with partial-onset seizures].
Saussele T
Med Monatsschr Pharm; 2008 Oct; 31(10):374-7. PubMed ID: 18972867
[TBL] [Abstract][Full Text] [Related]
8. The longer-term cognitive effects of adjunctive antiepileptic treatment with lacosamide in comparison with lamotrigine and topiramate in a naturalistic outpatient setting.
Helmstaedter C; Witt JA
Epilepsy Behav; 2013 Feb; 26(2):182-7. PubMed ID: 23318473
[TBL] [Abstract][Full Text] [Related]
9. Lacosamide, a novel anti-convulsant drug, shows efficacy with a wide safety margin in rodent models for epilepsy.
Stöhr T; Kupferberg HJ; Stables JP; Choi D; Harris RH; Kohn H; Walton N; White HS
Epilepsy Res; 2007 May; 74(2-3):147-54. PubMed ID: 17433624
[TBL] [Abstract][Full Text] [Related]
10. Sinus node dysfunction: an adverse effect of lacosamide.
Chinnasami S; Rathore C; Duncan JS
Epilepsia; 2013 Jun; 54(6):e90-3. PubMed ID: 23360388
[TBL] [Abstract][Full Text] [Related]
11. Effects of the novel antiepileptic drug lacosamide on the development of amygdala kindling in rats.
Brandt C; Heile A; Potschka H; Stoehr T; Löscher W
Epilepsia; 2006 Nov; 47(11):1803-9. PubMed ID: 17116018
[TBL] [Abstract][Full Text] [Related]
12. [Efficacy and safety of a new antiepileptic drug lacosamide in patients with focal epilepsy: data of double-blind placebo controlled trials].
Mil'chakova LE; Gekht AB
Zh Nevrol Psikhiatr Im S S Korsakova; 2010; 110(3 Suppl 2):39-43. PubMed ID: 20873472
[No Abstract] [Full Text] [Related]
13. The anti-epileptic drug lacosamide (Vimpat) has anxiolytic property in rodents.
Higgins GA; Breysse N; Undzys E; Kuo C; Joharchi N; Derksen DR; Xin T; Isaac M; Slassi M
Eur J Pharmacol; 2009 Dec; 624(1-3):1-9. PubMed ID: 19818346
[TBL] [Abstract][Full Text] [Related]
14. Remacemide--a novel potential antiepileptic drug.
Małek R; Borowicz KK; Kimber-Trojnar Z; Sobieszek G; Piskorska B; Czuczwar SJ
Pol J Pharmacol; 2003; 55(5):691-8. PubMed ID: 14704464
[TBL] [Abstract][Full Text] [Related]
15. Efficacy and tolerability of lacosamide as an adjunctive therapy in children with refractory partial epilepsy.
Pasha I; Kamate M; Didagi SK
Pediatr Neurol; 2014 Oct; 51(4):509-14. PubMed ID: 25266613
[TBL] [Abstract][Full Text] [Related]
16. A Well-Tolerated and Effective Antiepileptic Drug for Patients With Myasthenia Gravis at Last?
Sánchez-Villalobos JM; Villegas-Martínez I; Pérez-Vicente JA
Clin Neuropharmacol; 2018; 41(2):80-81. PubMed ID: 29432285
[TBL] [Abstract][Full Text] [Related]
17. Lacosamide.
Perucca E; Yasothan U; Clincke G; Kirkpatrick P
Nat Rev Drug Discov; 2008 Dec; 7(12):973-4. PubMed ID: 19043448
[TBL] [Abstract][Full Text] [Related]
18. Lacosamide use in refractory idiopathic primary generalized epilepsy.
Zangaladze A; Skidmore C
Epilepsy Behav; 2012 Jan; 23(1):79-80. PubMed ID: 22197124
[TBL] [Abstract][Full Text] [Related]
19. Pharmacotherapy of the third-generation AEDs: lacosamide, retigabine and eslicarbazepine acetate.
Patsalos PN; Berry DJ
Expert Opin Pharmacother; 2012 Apr; 13(5):699-715. PubMed ID: 22404663
[TBL] [Abstract][Full Text] [Related]
20. Effect of lacosamide on structural damage and functional recovery after traumatic brain injury in rats.
Pitkänen A; Immonen R; Ndode-Ekane X; Gröhn O; Stöhr T; Nissinen J
Epilepsy Res; 2014 May; 108(4):653-65. PubMed ID: 24636248
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]